GSTM1 and anemia: Fifty-five (33.33%) of participants had moderate anemia (Hb 8-10 g/dL) or severe anemia (Hb<8 g/dL), while 110 (66.67%) either had no anemia or mild anemia (Hb >10 g/dL).